Streekziekenhuis Koningin Beatrix
- Address
- Beatrixpark 1, 7101 BN Winterswijk, The Netherlands
Streekziekenhuis Koningin Beatrix - Oncology Research Center
Streekziekenhuis Koningin Beatrix is actively engaged in advancing cancer treatment through participation in large-scale clinical trials. The center demonstrates particular expertise in gastrointestinal oncology, focusing on post-surgical interventions and adjuvant therapies for colorectal malignancies.
- Stage II and III colon cancer adjuvant therapy research
- Chemoprevention strategies using acetylsalicylic acid
- Post-resection survival and recurrence prevention studies
The facility's research portfolio emphasizes evidence-based approaches to improving long-term outcomes for patients who have undergone resection of colon carcinoma. Through participation in Phase III randomized controlled trials, the center contributes to understanding how aspirin therapy may influence overall survival and disease recurrence in colorectal cancer patients, representing a commitment to exploring accessible and potentially cost-effective therapeutic strategies in oncology care.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 3 therapeutic areas and 15 of 25 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 271 other sites in The Netherlands
Therapeutic Area Benchmark — The Netherlands
Select a therapeutic area to compare against other sites in The Netherlands.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: The Netherlands
Market Share
Country: The Netherlands
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Streekziekenhuis Koningin Beatrix
lock Showing 1 of 7 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase III double-blind placebo-controlled Randomised Trial of Aspirin on Recurrence and Survival in Colon Cancer Patients | Leids Universitair Medisch Centrum (LUMC) | Phase III | Not Recruiting | Aug 2014 | — |
IMP list
lock Showing 1 of 25 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Capecitabine | 2 | Unknown | 2024-10-14 | 2026-07-08 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.